Literature DB >> 22820967

Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.

A Laria1, A Zoli, M Bocci, F Castri, F Federico, G F Ferraccioli.   

Abstract

Giant cell arteritis (GCA) is a vasculitis of large- vessels. A markedly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are characteristics of GCA, although temporal artery biopsy remains the gold standard for the diagnosis. We describe a case of biopsy-proven GCA showing a heavy infiltration of CD68 macrophages and CD3 T cells and with normal ESR and CRP levels at diagnosis. Key points (1) GCA may occur with normal ESR in a percentage of about 4 to 15 % (although the American College of Rheumatology classification criteria for giant cell arteritis include an ESR of 50 mm/h or more), while it can occur with normal ESR and normal CRP in a percentage of about 0.8 %. So, the clinical suspicion must be confirmed with a positive biopsy. (2) GCA patients with ESR >40 mm/h are characterized by higher incidence of headache and jaw claudication compared to patients with normal ESR. In our case, it occurred with normal ESR. (3) Color duplex ultrasonography is a noninvasive, easy, and inexpensive method for supporting a diagnosis of TA, with a high sensitivity and specificity. It can predict which patient will need TAB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820967     DOI: 10.1007/s10067-012-2031-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

Review 1.  Does this patient have temporal arteritis?

Authors:  Gerald W Smetana; Robert H Shmerling
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

2.  Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval.

Authors:  A T Olsson; H Elling; P Elling
Journal:  Arthritis Rheum       Date:  1997-01

3.  The role of unilateral temporal artery biopsy.

Authors:  Jennifer K Hall; Nicholas J Volpe; Steven L Galetta; Grant T Liu; Nasreen A Syed; Laura J Balcer
Journal:  Ophthalmology       Date:  2003-03       Impact factor: 12.079

4.  Erythrocyte sedimentation rate in temporal arteritis.

Authors:  G Branum; E W Massey; J Rice
Journal:  South Med J       Date:  1987-12       Impact factor: 0.954

5.  Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis.

Authors:  Hisham M Habib; Ashraf A Essa; Ayman A Hassan
Journal:  Clin Rheumatol       Date:  2011-07-09       Impact factor: 2.980

6.  A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.

Authors:  G Myklebust; J T Gran
Journal:  Br J Rheumatol       Date:  1996-11

7.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

8.  Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.

Authors:  O N Pamuk; S Dönmez; B Karahan; G E Pamuk; N Cakir
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

Review 9.  Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases.

Authors:  C M Wise; C A Agudelo; W L Chmelewski; K M McKnight
Journal:  Arthritis Rheum       Date:  1991-12

10.  Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia.

Authors:  J W Jundt; D Mock
Journal:  Arthritis Rheum       Date:  1991-02
View more
  7 in total

1.  Giant cell arteritis with normal ESR and/or CRP is rare, but not unique!

Authors:  A Grzybowski; A Justynska
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

2.  Response to Grzybowski and Justynska.

Authors:  S L Levy; A D Bull; A R Nestel
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

3.  Giant cell arteritis with normal C-reactive protein and risk of ocular complications.

Authors:  Francisco José Fernández-Fernández; Gonzalo Pía; Pascual Sesma
Journal:  Clin Rheumatol       Date:  2012-08-21       Impact factor: 2.980

Review 4.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

Review 5.  Recent Advances in Giant Cell Arteritis.

Authors:  M Guevara; C S Kollipara
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

6.  Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica.

Authors:  Ciro Manzo
Journal:  Reumatologia       Date:  2016-11-28

Review 7.  Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.

Authors:  Enrico Tombetti; Elvis Hysa; Justin C Mason; Marco A Cimmino; Dario Camellino
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.